Ann: BTM delivers positive First in Man results in Cell Therapies, page-202

  1. 3,400 Posts.
    lightbulb Created with Sketch. 270
    I know type 1 is different to type 1 but the point is there are many technical advancement in this field going on...!

    important point is everything that you are simply a drilling material company not the owner of the beta cell and even if you became owner then get ready for huge dilution and many many years worth roller coaster ride ....only if you believe in luck then worth it...!

    so to avoid all just remove chairman and get new board and CEO that works for PNV not self ego
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.22
Change
0.000(0.00%)
Mkt cap ! $839.3M
Open High Low Value Volume
$1.22 $1.25 $1.21 $1.808M 1.476M

Buyers (Bids)

No. Vol. Price($)
4 14866 $1.21
 

Sellers (Offers)

Price($) Vol. No.
$1.22 12554 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.